India's drug regulator CDSCO has found 53 drugs to be of non-standard quality in its latest test, which includes popular medicines like paracetamol, Vitamin D supplements, and antibiotics. These drugs are manufactured by various companies, including state-owned Hindustan Antibiotics. Some of these medicines were also linked to the deaths of 12 children in J&K in 2020, prompting tighter quality inspection measures in Gambia. In response to these findings, the CDSCO has revoked the power of state and UT authorities to grant no-objection-certificates for export purposes, and companies who received approvals in the past will have to report them to the central drug regulators. Stay updated with Fortune India on social media for more updates.
India Uncovers Substandard Drugs, Prompting Stringent Inspections
The Central Drugs Standard Control Organization (CDSCO), India's drug regulator, has exposed a startling trend in the country's pharmaceutical industry: 53 drugs of subpar quality. This discovery has sent shockwaves through the medical community and has led to heightened concerns about the safety of medications available to the public.
Background
India is a major player in the global pharmaceutical market, exporting drugs to over 200 countries. However, the revelation of substandard drugs raises questions about the quality control and regulatory oversight of the industry. In the past, India has been plagued by drug scandals involving fake and adulterated medicines.
The Latest Findings
The 53 subpar drugs include popular medicines such as paracetamol, Vitamin D supplements, and antibiotics. They were manufactured by various companies, including state-owned Hindustan Antibiotics. Some of the affected medicines were reportedly linked to the deaths of 12 children in Jammu and Kashmir in 2020.
Response from CDSCO
In light of these findings, the CDSCO has taken swift action:
Top 5 FAQs and Answers
1. What is the concern with the substandard drugs?
Answer: The drugs may not meet appropriate standards of purity, potency, or efficacy, potentially compromising patient safety.
2. Why were the drugs declared substandard?
Answer: The CDSCO conducted tests and found discrepancies in the composition, disintegration times, and other quality parameters.
3. What is being done to address the issue?
Answer: The CDSCO is conducting further investigations and revoking export approvals for affected companies. The government is also considering strengthening regulatory oversight of the pharmaceutical industry.
4. What should patients do if they have been taking the affected drugs?
Answer: Patients should consult with their healthcare providers to discuss alternative medications or further monitoring.
5. What measures are being taken to prevent future incidents?
Answer: The CDSCO is implementing stricter quality control procedures, increasing inspections, and considering enhanced penalties for manufacturers found in violation.
Conclusion
The discovery of substandard drugs in India highlights the importance of vigilant oversight and stringent regulation in the pharmaceutical industry. The CDSCO's swift response and the government's commitment to strengthen quality control measures demonstrate a determination to protect public health and ensure the safety of medications used by the nation's citizens.
Zomato, the popular food delivery platform, has announced an increase in its platform fee from Rs 7 to Rs 10 in preparation for the upcoming festive season. This move is expected to bring an additional Rs 65 crore to the company's revenue annually. Zomato's profits for the second quarter were lower than expected due to investments in its "dark stores" for online orders. The company has also approved a fundraise of up to Rs 8,500 crore to boost its cash reserves after its recent acquisition of a digital payment firm's movie and events ticketing businesses. With competition in the online food and grocery delivery sector heating up, Zomato's move to increase its platform fee may give them an edge in gaining market share.
Zomato's board of directors has approved a plan to raise Rs 8,500 crore through equity shares, following its impressive Q2FY25 earnings report. Analysts have shown strong confidence in the food delivery company's future, with leading brokerages raising their price targets and recommending a "Buy" stance. While some have maintained a more conservative outlook, the overall sentiment points towards growing market confidence in Zomato's ability to thrive in the competitive food delivery landscape.
A recent survey revealed that a lack of recognition, rude managers, and outdated technology are the top demotivators for office staff. In response, Brother UK has launched the Fabulous Feedback Formula, a tool designed to help workers give tactful feedback in difficult situations. The research highlights the important role managers play in creating a positive work environment, making this tool a valuable resource for all levels of employees.
Union Bank of India and Zoho have collaborated to develop CRM Edge, a cutting-edge customer engagement platform that has revolutionized the bank's digital transformation journey. With its innovative features such as eKYC and automated workflows, the platform has significantly improved customer acquisition, retention, and satisfaction, aligning with the bank's growth plans. The successful partnership between the two organizations has set a new standard in the realm of digital banking.
In a major turnaround, the Supreme Court has overturned the National Company Law Appellate Tribunal's verdict that had put a hold on insolvency proceedings against ed-tech company Byju's. The apex court also reversed the NCLAT's order approving Byju's settlement of Rs 158.9 crore with the Board of Control for Cricket in India (BCCI). The decision came after US firm Glas Trust Company LLC appealed against the NCLAT's order, with the apex court stating that the tribunal didn't apply its mind while closing the insolvency proceedings against Byju's. The verdict marks a major setback for Byju's, which had received a brief reprieve after the NCLAT's ruling in its favor.
The Minister of Communication, Shri Jyotiraditya M Scindia, unveiled the new logo of state-run telecom BSNL, which represents the company's mission to connect India securely, affordably, and reliably. Along with the new logo, BSNL also launched seven new initiatives, including automatic spam blocking, free wi-fi, and low-latency 5G, all designed to cater to the needs of the Indian population. This event marks BSNL's commitment to connecting every citizen of Bharat and empowering them with advanced communication services.
RediffGurus, a prestigious research center, has revealed that Harshil Agrotech Ltd. has shown remarkable progress in the past 15 days, according to the latest data from Rediff.com. This news has sparked excitement in the business world, with predictions of a promising future for the company. Investors and experts are keeping a close eye on Harshil Agrotech Ltd. as it continues to establish itself as a top player in the market, with a potential of great financial returns in the near future.
A meeting involving Air India and Vistara was held this Tuesday evening, with the Union Ministry of Electronics and Information Technology reprimanding social media platform X for circulating bomb threat hoaxes. The ministry also advised social media platforms to use AI-based mechanisms to block any accounts sending out bulk messages about bombs. Over the past eight days, more than 170 flights operated by Indian carriers have received bomb threats, prompting authorities to urge social media platforms to take immediate action.
In a session marked by selling pressure in financial, auto, and FMCG shares, the Nifty50 and Sensex closed lower, with the Sensex down 0.3% and Nifty50 down 0.1%. The market saw only brief moves above the flatline, with the Nifty50 moving within the 24,900-25,000 range. The top losers in the Nifty50 basket included M&M, ICICI Bank, Cipla, Adani Enterprises, and Maruti Suzuki, while top gainers included Trent, Hindalco, HCLTech, Tech Mahindra, ONGC, and JSW Steel. Despite the overall weak market trend, midcap and smallcap shares bucked the trend, with gains of 0.5% each in the Nifty Midcap and Nifty Smallcap indices. Keep up with the latest stock market updates and all other business news on Zeebiz.com.
Despite a much-anticipated IPO, Hyundai Motor India's shares debuted below the expected price, causing disappointment among investors. However, the company has announced plans to expand into the lucrative electric vehicle market in India and modernize its plant in Tamil Nadu with an investment of Rs 1,500 crores. This move comes as the company aims to establish itself as a leader in the Indian automobile industry and cater to the increasing demand for environmentally friendly vehicles.